332 related articles for article (PubMed ID: 20433909)
1. Neuregulin 1-erbB4 pathway in schizophrenia: From genes to an interactome.
Banerjee A; Macdonald ML; Borgmann-Winter KE; Hahn CG
Brain Res Bull; 2010 Sep; 83(3-4):132-9. PubMed ID: 20433909
[TBL] [Abstract][Full Text] [Related]
2. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia.
Hahn CG; Wang HY; Cho DS; Talbot K; Gur RE; Berrettini WH; Bakshi K; Kamins J; Borgmann-Winter KE; Siegel SJ; Gallop RJ; Arnold SE
Nat Med; 2006 Jul; 12(7):824-8. PubMed ID: 16767099
[TBL] [Abstract][Full Text] [Related]
3. Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.
Deng C; Pan B; Engel M; Huang XF
Psychopharmacology (Berl); 2013 Mar; 226(2):201-15. PubMed ID: 23389757
[TBL] [Abstract][Full Text] [Related]
4. Neuregulin 1 Type I Overexpression Is Associated with Reduced NMDA Receptor-Mediated Synaptic Signaling in Hippocampal Interneurons Expressing PV or CCK.
Kotzadimitriou D; Nissen W; Paizs M; Newton K; Harrison PJ; Paulsen O; Lamsa K
eNeuro; 2018; 5(2):. PubMed ID: 29740596
[TBL] [Abstract][Full Text] [Related]
5. Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls.
Nicodemus KK; Law AJ; Radulescu E; Luna A; Kolachana B; Vakkalanka R; Rujescu D; Giegling I; Straub RE; McGee K; Gold B; Dean M; Muglia P; Callicott JH; Tan HY; Weinberger DR
Arch Gen Psychiatry; 2010 Oct; 67(10):991-1001. PubMed ID: 20921115
[TBL] [Abstract][Full Text] [Related]
6. Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors.
Pitcher GM; Kalia LV; Ng D; Goodfellow NM; Yee KT; Lambe EK; Salter MW
Nat Med; 2011 Apr; 17(4):470-8. PubMed ID: 21441918
[TBL] [Abstract][Full Text] [Related]
7. Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia.
Norton N; Moskvina V; Morris DW; Bray NJ; Zammit S; Williams NM; Williams HJ; Preece AC; Dwyer S; Wilkinson JC; Spurlock G; Kirov G; Buckland P; Waddington JL; Gill M; Corvin AP; Owen MJ; O'Donovan MC
Am J Med Genet B Neuropsychiatr Genet; 2006 Jan; 141B(1):96-101. PubMed ID: 16249994
[TBL] [Abstract][Full Text] [Related]
8. Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene.
Buxbaum JD; Georgieva L; Young JJ; Plescia C; Kajiwara Y; Jiang Y; Moskvina V; Norton N; Peirce T; Williams H; Craddock NJ; Carroll L; Corfas G; Davis KL; Owen MJ; Harroch S; Sakurai T; O'Donovan MC
Mol Psychiatry; 2008 Feb; 13(2):162-72. PubMed ID: 17579610
[TBL] [Abstract][Full Text] [Related]
9. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia.
Mei L; Xiong WC
Nat Rev Neurosci; 2008 Jun; 9(6):437-52. PubMed ID: 18478032
[TBL] [Abstract][Full Text] [Related]
10. Perinatal phencyclidine treatment alters neuregulin 1/erbB4 expression and activation in later life.
du Bois TM; Newell KA; Huang XF
Eur Neuropsychopharmacol; 2012 May; 22(5):356-63. PubMed ID: 21962913
[TBL] [Abstract][Full Text] [Related]
11. A neuregulin 1 transmembrane domain mutation causes imbalanced glutamatergic and dopaminergic receptor expression in mice.
Newell KA; Karl T; Huang XF
Neuroscience; 2013 Sep; 248():670-80. PubMed ID: 23811072
[TBL] [Abstract][Full Text] [Related]
12. Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1+/- knock-outs compared with wild-type mice.
Bjarnadottir M; Misner DL; Haverfield-Gross S; Bruun S; Helgason VG; Stefansson H; Sigmundsson A; Firth DR; Nielsen B; Stefansdottir R; Novak TJ; Stefansson K; Gurney ME; Andresson T
J Neurosci; 2007 Apr; 27(17):4519-29. PubMed ID: 17460065
[TBL] [Abstract][Full Text] [Related]
13. Neuregulin1/ErbB4-induced migration in ST14A striatal progenitors: calcium-dependent mechanisms and modulation by NMDA receptor activation.
Pregno G; Zamburlin P; Gambarotta G; Farcito S; Licheri V; Fregnan F; Perroteau I; Lovisolo D; Bovolin P
BMC Neurosci; 2011 Oct; 12():103. PubMed ID: 21991932
[TBL] [Abstract][Full Text] [Related]
14. Schizophrenia: more evidence for less glutamate.
Morrison PD; Pilowsky LS
Expert Rev Neurother; 2007 Jan; 7(1):29-31. PubMed ID: 17187494
[TBL] [Abstract][Full Text] [Related]
15. Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy.
Law AJ; Wang Y; Sei Y; O'Donnell P; Piantadosi P; Papaleo F; Straub RE; Huang W; Thomas CJ; Vakkalanka R; Besterman AD; Lipska BK; Hyde TM; Harrison PJ; Kleinman JE; Weinberger DR
Proc Natl Acad Sci U S A; 2012 Jul; 109(30):12165-70. PubMed ID: 22689948
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal signalling between NR2 subunits of the NMDA receptor and neuregulin1 and their role in schizophrenia.
Geddes AE; Huang XF; Newell KA
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):896-904. PubMed ID: 21371516
[TBL] [Abstract][Full Text] [Related]
17. Discovery, validation and characterization of Erbb4 and Nrg1 haplotypes using data from three genome-wide association studies of schizophrenia.
Agim ZS; Esendal M; Briollais L; Uyan O; Meschian M; Martinez LA; Ding Y; Basak AN; Ozcelik H
PLoS One; 2013; 8(1):e53042. PubMed ID: 23301017
[TBL] [Abstract][Full Text] [Related]
18. Neuregulin 1 and susceptibility to schizophrenia.
Stefansson H; Sigurdsson E; Steinthorsdottir V; Bjornsdottir S; Sigmundsson T; Ghosh S; Brynjolfsson J; Gunnarsdottir S; Ivarsson O; Chou TT; Hjaltason O; Birgisdottir B; Jonsson H; Gudnadottir VG; Gudmundsdottir E; Bjornsson A; Ingvarsson B; Ingason A; Sigfusson S; Hardardottir H; Harvey RP; Lai D; Zhou M; Brunner D; Mutel V; Gonzalo A; Lemke G; Sainz J; Johannesson G; Andresson T; Gudbjartsson D; Manolescu A; Frigge ML; Gurney ME; Kong A; Gulcher JR; Petursson H; Stefansson K
Am J Hum Genet; 2002 Oct; 71(4):877-92. PubMed ID: 12145742
[TBL] [Abstract][Full Text] [Related]
19. Association and interaction analyses of NRG1 and ERBB4 genes with schizophrenia in a Japanese population.
Shiota S; Tochigi M; Shimada H; Ohashi J; Kasai K; Kato N; Tokunaga K; Sasaki T
J Hum Genet; 2008; 53(10):929-935. PubMed ID: 18704261
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic treatment and neuregulin 1-ErbB4 signalling in schizophrenia.
Pan B; Huang XF; Deng C
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):924-30. PubMed ID: 21513767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
